Location: Institute of Cell Biology and Immunology at the University of Stuttgart (Germany).
Project background and description:
The overall objective of this project is to develop and validate statistical and systems biology-based patient stratification tools for the personalised treatment of melanoma patients. As part of the EU FP7 SYS-MEL consortium, the candidate will be responsible for the analysis of clinicopathological patient data and quantitative protein data, such as key players of epigenetic expression control and apoptosis regulation. Comprehensive data from multiple patient cohorts has been collected by the SYS-MEL consortium over the past two years and are available for this work. For statistical and systems biological analyses, prototype workflows and models are available and can be extended further as needed for this project. Where necessary, further data curation and annotation in collaboration with clinical partners may form part of the activities. The research consortium operates as a highly interdisciplinary research network between academic, clinical and private sector partners. Excellent communication skills and the ability and willingness to operate at the interface of multiple, traditionally separated disciplines is a key requirement for this position.
Closing date: Applications must be received by 29th of February 2016, 5pm.